- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00769912
Evaluation of of a Prefixed 50% N2O- 50%O2 Mixture in Legal Abortion Under Local Analgesia
August 28, 2014 updated by: Assistance Publique Hopitaux De Marseille
To evaluate effectiveness of a prefixed 50% N2O- 50%O2 mixture in legal abortion under paracervical block.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13005
- Service de Gynécologie Obstétrique, Hôpital La Conception
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Major patient having signed an assent waits having chosen to make the intervention under local anesthetic
Exclusion Criteria:
- Minor
- contraindication in the use of the paracetamol, the lidocaine
- Porphyries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
50% N2O- 50%O2 mixture administration during the intervention
|
50% N2O- 50%O2 mixture administration
|
Placebo Comparator: 2
Placebo (air) during the intervention
|
Placebo administration during the intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain during the intervention
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain at the end of the intervention and 2 hours after. Unwanted events
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Aubert AGOSTINI, MD, Assistance Publique des Hôpitaux de Marseille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
February 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
October 8, 2008
First Submitted That Met QC Criteria
October 8, 2008
First Posted (Estimate)
October 9, 2008
Study Record Updates
Last Update Posted (Estimate)
August 29, 2014
Last Update Submitted That Met QC Criteria
August 28, 2014
Last Verified
January 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- 2008-000799-25
- 2008-10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abortion
-
IpasSt. Paul's Hospital Millennium Medical College, Addis Ababa, EthiopiaCompletedMedical Abortion | Induced Abortion | Second Trimester Abortion | Health PersonnelEthiopia
-
Marie Stopes InternationalLondon School of Hygiene and Tropical Medicine; IpasCompletedContraception | Abortion | Post-abortionBangladesh
-
National University of MalaysiaRecruitingMedical; Abortion, Fetus | Missed Abortion | Incomplete AbortionMalaysia
-
IpasUnknownInduced Abortion | First Trimester AbortionNigeria
-
Boston UniversityCompletedAbortion, Induced | Abortion, Second TrimesterUnited States
-
Central Hospital, Nancy, FranceCompletedAbortion in First Trimester | Abortion, Second Trimester
-
Carmel Medical CenterUnknownMissed Abortion | Incomplete Abortion | Uterine Gestational Residua | Uterine Artery DopplerIsrael
-
Boston UniversityCompletedAbortion, Induced | Abortion, Second TrimesterUnited States
-
NHS LothianCompletedAbortion in First Trimester | Abortion EarlySweden, United Kingdom, France
-
NHS LothianUniversity of EdinburghTerminatedAbortion in First Trimester | Abortion EarlyUnited Kingdom
Clinical Trials on 50% N2O- 50%O2 mixture
-
University of PadovaPerforma di Crocicchia SrlCompleted
-
University of IowaRecruiting
-
Lawson Health Research InstituteCompletedPostoperative Air LeakCanada
-
Aichi Gakuin UniversityUnknown
-
VA Office of Research and DevelopmentWhite River Junction Veterans Affairs Medical CenterCompletedPhysician Survey Response Rates
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Laboratorios Leti, S.L.CompletedAllergy | Rhinitis | Rhinoconjunctivitis | Seasonal AsthmaSpain